Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Pittsburgh Financial Group CEO Andrew Pravlik Makes Generous Donation to the Cystic Fibrosis Foundation


News provided by

The Cystic Fibrosis Foundation

Jun 23, 2023, 16:30 ET

Share this article

Share toX

Share this article

Share toX


The Cystic Fibrosis Foundation, the world's leader in the search for a cure for cystic fibrosis which supports a broad range of research initiatives to tackle the disease from all angles, today announced a donation made by Pittsburgh Financial Group's CEO Andrew Pravlik, along with his COO Gina McCafferty.

PITTSBURGH, June 23, 2023 /PRNewswire-PRWeb/ -- The Cystic Fibrosis Foundation, the world's leader in the search for a cure for cystic fibrosis which supports a broad range of research initiatives to tackle the disease from all angles, today announced a donation made by Pittsburgh Financial Group's CEO Andrew Pravlik, along with his COO Gina McCafferty. Pravlik's initial donation serves as a sponsorship for Channing Powell, an annual honoree of "Pittsburgh's 50 Finest" young professionals, who is raising funds to support the Foundation's mission of controlling and curing cystic fibrosis.

Cystic fibrosis (CF) is a genetic disorder that primarily affects the lungs and digestive system. It is caused by a mutation in the CFTR gene, which leads to the production of thick and sticky mucus in the body. This mucus clogs the airways and obstructs the pancreas, leading to difficulties in breathing and proper digestion. CF is a chronic and progressive disease that affects each individual differently, with symptoms ranging from persistent coughing and frequent lung infections to poor weight gain and nutritional deficiencies. The impact of CF extends beyond physical symptoms, as it requires lifelong management and can significantly impact the quality of life for those affected and their families.

"I am honored to support the Cystic Fibrosis Foundation and join forces with outstanding young professionals like Channing Powell."

Post this

The Cystic Fibrosis Foundation is on a mission to cure cystic fibrosis and improve the lives of those affected by this devastating disease. Their work is centered around three core areas: research, care, and support. The Foundation is a global leader in funding innovative and groundbreaking cystic fibrosis research, investing hundreds of millions of dollars into research and drug development. Their efforts have led to significant advancements, resulting in longer and healthier lives for individuals with cystic fibrosis. Additionally, the Foundation provides expert care through a nationwide network of accredited care centers, ensuring that each person with CF receives personalized and tailored treatment. They also strive to support individuals and families by providing access to the necessary tools and resources for leading healthy lives. The impact of the Cystic Fibrosis Foundation's work is evident in the significant increase in life expectancy for those with CF over the past few decades. Today, people with cystic fibrosis are not only surviving but thriving, with many living into their 30s, 40s, and beyond. The Foundation's support has been instrumental in the development of nearly every CF drug available, and they continue to advocate for access to quality care and resources for all individuals with CF.

Pravlik's donation and support of Channing Powell's fundraising efforts showcase his commitment to making a difference in the lives of those affected by CF. Pravlik stated,

"I am honored to support the Cystic Fibrosis Foundation and join forces with outstanding young professionals like Channing Powell. Together, we can make a significant impact on the lives of those affected by cystic fibrosis. By contributing to this important cause, we are helping to fund research, advance treatments, and provide support to individuals and families impacted by this challenging disease. It is our collective efforts that will bring us closer to a cure and improve the quality of life for those living with cystic fibrosis."

Powell, an outstanding young professional and honoree of Pittsburgh's 50 Finest, is passionate about raising awareness and funds to further the Foundation's mission. With her personal goal of raising $10,000, Powell and her fellow honorees will be celebrated at Pittsburgh's 50 Finest Finale Celebration, an elegant evening of dinner, refreshments, and entertainment, on Friday, September 29, 2023.

The event provides an opportunity for honorees to network, socialize, and raise awareness for cystic fibrosis. Through their involvement, these prominent, influential, and successful young professionals contribute to the local CF community by advocating for resources and support. Together, their efforts contribute to the Foundation's mission of controlling and curing cystic fibrosis.

For more information please visit http://www.cff.org

About The Cystic Fibrosis Foundation
The Cystic Fibrosis Foundation, established in 1955 by a group of determined parents, has made remarkable strides in combating cystic fibrosis (CF). Previously, children born with CF had a bleak prognosis, but through extensive research, drug development, and specialized care, the foundation has doubled the life expectancy of individuals with CF over the past 30 years. Today, people with CF are living longer, healthier lives and achieving milestones once thought impossible. The foundation's investments in research have led to groundbreaking discoveries, resulting in the development of drugs that address the underlying causes of CF. Furthermore, the foundation provides expert care through accredited centers and advocates for access to essential resources, ensuring a brighter future for those with CF.

About Andrew Pravlik
Andrew Pravlik is a seasoned financial services professional with over 30 years of experience. Recently appointed as the CEO, President, and Managing Partner of Pittsburgh Financial Group, he has also taken charge of their western subsidiary, Seattle Financial Group. Under Pravlik's leadership, Pittsburgh Financial Group has witnessed rapid growth in clients and assets.

With a specialization in retirement plans and 401k rollovers, Pravlik takes pride in receiving numerous referrals that allow him to serve multiple generations within the same families. He holds several securities licenses, including Series 7, 63, and 66, as well as the Securities Industry Essentials® (SIE®) Certification. Additionally, he is fully licensed in life insurance, annuities, fixed index annuities, and long-term care insurance, making him well-equipped to assist clients in achieving their financial goals.

Media Contact

Andrew Pravlik, PGH Financial, 8889753331, info@reputationrhino.com

SOURCE The Cystic Fibrosis Foundation

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.